Literature DB >> 14766177

Regulation of AMPA receptor gating by ligand binding core dimers.

Michelle S Horning1, Mark L Mayer.   

Abstract

Ionotropic glutamate receptors are tetramers, the isolated ligand binding cores of which assemble as dimers. Previous work on nondesensitizing AMPA receptor mutants, which combined crystallography, ultracentrifugation, and patch-clamp recording, showed that dimer formation by the ligand binding cores is required for activation of ion channel gating by agonists. To define the mechanisms responsible for stabilization of dimer assembly in native AMPA receptors, contacts between the adjacent ligand binding cores were individually targeted by amino acid substitutions, using the GluR2 crystal structure as a guide to design mutants. We show that disruption of a salt bridge, hydrogen bond network, and intermolecular van der Waals contacts between helices D and J in adjacent ligand binding cores greatly accelerates desensitization. Conservation of these contacts in AMPA and kainate receptors indicates that they are important determinants of dimer stability and that the dimer interface is a key structural element in the gating mechanism of these glutamate receptor families.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14766177     DOI: 10.1016/s0896-6273(04)00018-2

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  59 in total

Review 1.  Glutamate receptor ion channels: structure, regulation, and function.

Authors:  Stephen F Traynelis; Lonnie P Wollmuth; Chris J McBain; Frank S Menniti; Katie M Vance; Kevin K Ogden; Kasper B Hansen; Hongjie Yuan; Scott J Myers; Ray Dingledine
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

Review 2.  Control of assembly and function of glutamate receptors by the amino-terminal domain.

Authors:  Kasper B Hansen; Hiro Furukawa; Stephen F Traynelis
Journal:  Mol Pharmacol       Date:  2010-07-21       Impact factor: 4.436

Review 3.  Emerging models of glutamate receptor ion channel structure and function.

Authors:  Mark L Mayer
Journal:  Structure       Date:  2011-10-12       Impact factor: 5.006

4.  The transmembrane AMPA receptor regulatory protein gamma 4 is a more effective modulator of AMPA receptor function than stargazin (gamma 2).

Authors:  Christoph Körber; Markus Werner; Sabine Kott; Zhan-Lu Ma; Michael Hollmann
Journal:  J Neurosci       Date:  2007-08-01       Impact factor: 6.167

5.  Subunit-subunit interactions are critical for proton sensitivity of ROMK: evidence in support of an intermolecular gating mechanism.

Authors:  Qiang Leng; Gordon G MacGregor; Ke Dong; Gerhard Giebisch; Steven C Hebert
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-30       Impact factor: 11.205

6.  Targeting AMPA receptor gating processes with allosteric modulators and mutations.

Authors:  Nicholas A Mitchell; Mark W Fleck
Journal:  Biophys J       Date:  2007-01-05       Impact factor: 4.033

7.  Concanavalin-A reports agonist-induced conformational changes in the intact GluR6 kainate receptor.

Authors:  Anne-Marie L Fay; Derek Bowie
Journal:  J Physiol       Date:  2006-01-26       Impact factor: 5.182

8.  A domain linking the AMPA receptor agonist binding site to the ion pore controls gating and causes lurcher properties when mutated.

Authors:  Sabine M Schmid; Christoph Körber; Solveig Herrmann; Markus Werner; Michael Hollmann
Journal:  J Neurosci       Date:  2007-11-07       Impact factor: 6.167

9.  Modulation of the dimer interface at ionotropic glutamate-like receptor delta2 by D-serine and extracellular calcium.

Authors:  Kasper B Hansen; Peter Naur; Natalie L Kurtkaya; Anders S Kristensen; Michael Gajhede; Jette S Kastrup; Stephen F Traynelis
Journal:  J Neurosci       Date:  2009-01-28       Impact factor: 6.167

10.  Stargazin reduces desensitization and slows deactivation of the AMPA-type glutamate receptors.

Authors:  Avi Priel; Alexander Kolleker; Gai Ayalon; Moshe Gillor; Pavel Osten; Yael Stern-Bach
Journal:  J Neurosci       Date:  2005-03-09       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.